The forecasted re-import of tetracyclines to France from 2024 to 2028 shows a steady, albeit slight, increase in volume each year, beginning at 19.36 thousand kilograms in 2024 and reaching 19.53 thousand kilograms by 2028. This consistent rise represents a gradual upward trend over the specified period. The year-on-year growth rate is minimal, indicating stable demand without significant fluctuations between 2024 and 2028. The compound annual growth rate (CAGR) should be less than 1%, showing modest growth over this five-year span.
Future trends to watch for:
- Potential changes in France's pharmaceutical regulations affecting re-importation.
- Global supply chain shifts impacting tetracycline availability and pricing.
- Developments in antibiotic resistance influencing demand for tetracyclines.
- Emerging competition from alternative antibiotics or new innovative treatment methods.
